Evidence map›Paper›PMID 24914194›Full record

ArticleHypertension (Dallas, Tex. : 1979)2014

Interference with peroxisome proliferator-activated receptor-γ in vascular smooth muscle causes baroreflex impairment and autonomic dysfunction.

Giulianna R Borges, Donald A Morgan, Pimonrat Ketsawatsomkron, Aaron D Mickle, Anthony P Thompson, Martin D Cassell, Durga P Mohapatra, Kamal Rahmouni, Curt D Sigmund

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

  • Commented on by
5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Giulianna R BorgesFrom the Department of Pharmacology (G.R.B., D.A.M., P.K., A.D.M., D.P.M., K.R., C.D.S.), Department of Anatomy and Cell Biology (A.P.T., M.D.C.), and Center on the Functional Genomics of Hypertension (K.R., C.D.S.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Donald A MorganFrom the Department of Pharmacology (G.R.B., D.A.M., P.K., A.D.M., D.P.M., K.R., C.D.S.), Department of Anatomy and Cell Biology (A.P.T., M.D.C.), and Center on the Functional Genomics of Hypertension (K.R., C.D.S.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Pimonrat KetsawatsomkronFrom the Department of Pharmacology (G.R.B., D.A.M., P.K., A.D.M., D.P.M., K.R., C.D.S.), Department of Anatomy and Cell Biology (A.P.T., M.D.C.), and Center on the Functional Genomics of Hypertension (K.R., C.D.S.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Aaron D MickleFrom the Department of Pharmacology (G.R.B., D.A.M., P.K., A.D.M., D.P.M., K.R., C.D.S.), Department of Anatomy and Cell Biology (A.P.T., M.D.C.), and Center on the Functional Genomics of Hypertension (K.R., C.D.S.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Anthony P ThompsonFrom the Department of Pharmacology (G.R.B., D.A.M., P.K., A.D.M., D.P.M., K.R., C.D.S.), Department of Anatomy and Cell Biology (A.P.T., M.D.C.), and Center on the Functional Genomics of Hypertension (K.R., C.D.S.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Martin D CassellFrom the Department of Pharmacology (G.R.B., D.A.M., P.K., A.D.M., D.P.M., K.R., C.D.S.), Department of Anatomy and Cell Biology (A.P.T., M.D.C.), and Center on the Functional Genomics of Hypertension (K.R., C.D.S.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Durga P MohapatraFrom the Department of Pharmacology (G.R.B., D.A.M., P.K., A.D.M., D.P.M., K.R., C.D.S.), Department of Anatomy and Cell Biology (A.P.T., M.D.C.), and Center on the Functional Genomics of Hypertension (K.R., C.D.S.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Kamal RahmouniFrom the Department of Pharmacology (G.R.B., D.A.M., P.K., A.D.M., D.P.M., K.R., C.D.S.), Department of Anatomy and Cell Biology (A.P.T., M.D.C.), and Center on the Functional Genomics of Hypertension (K.R., C.D.S.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Curt D SigmundFrom the Department of Pharmacology (G.R.B., D.A.M., P.K., A.D.M., D.P.M., K.R., C.D.S.), Department of Anatomy and Cell Biology (A.P.T., M.D.C.), and Center on the Functional Genomics of Hypertension (K.R., C.D.S.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City. curt-sigmund@uiowa.edu.
University of Iowa · US

Funding

Role of the brain Renin-Angiotensin Sys. in Cardiovas and Metabolic RegulationP01HL084207 · NHLBI · UNIVERSITY OF IOWA · PI GROBE, JUSTIN L · 2007 to 2022
$30.2M
Vascular Protection During HypertensionP01HL062984 · NHLBI · UNIVERSITY OF IOWA · PI HEISTAD, DONALD D · 2000 to 2015
$22.2M
SIGNIFICANCE OF ANGIOTENSINOGEN VARIANTS IN HYPERTENSIONR01HL061446 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 1999 to 2013
$4.8M
Role of Enhancers Regulating Renin Gene ExpressionR37HL048058 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 2006 to 2015
$4.3M
Interdisciplinary Training Program in Pain ResearchT32NS045549 · NINDS · UNIVERSITY OF IOWA · PI KATHLEEN A SLUKA, Yuriy M Usachev · 2004 to 2026
$3.7M
TRANSGENIC STUDIES OF THE HUMAN RENIN-ANGIOTENSIN SYSTEMR01HL048058 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 1993 to 2004
$1.8M
Chemokines, TRP Channels and Cancer PainR01NS069898 · NINDS · WASHINGTON UNIVERSITY · PI MOHAPATRA, DURGA PRASANNA · 2011 to 2015
$1.6M
PTHrP Modulation of TRPV1 in Pain Associated with Breast Cancer Bone MetastasisF31CA171927 · NCI · UNIVERSITY OF IOWA · PI MICKLE, AARON DAVID · 2012 to 2014
$67k
NCI NIH HHS F31 CA171927NHLBI NIH HHS P01 HL062984NHLBI NIH HHS P01 HL084207NHLBI NIH HHS R01 HL048058NHLBI NIH HHS R01 HL061446NHLBI NIH HHS R37 HL048058NINDS NIH HHS R01 NS069898NINDS NIH HHS T32 NS045549
6 · The paper itself

Abstract

S-P467L mice expressing dominant negative peroxisome proliferator-activated receptor-γ selectively in vascular smooth muscle exhibit impaired vasodilation, augmented vasoconstriction, hypertension, and tachycardia. We hypothesized that tachycardia in S-P467L mice is a result of baroreflex dysfunction. S-P467L mice displayed increased sympathetic traffic to the heart and decreased baroreflex gain and effectiveness. Carotid arteries exhibited inward remodeling but no changes in distensibility or stress/strain. Aortic depressor nerve activity in response to increased arterial pressure was blunted in S-P467L mice. However, the arterial pressure and heart rate responses to aortic depressor nerve stimulation were unaltered in S-P467L mice, suggesting that the central and efferent limbs of the baroreflex arc remain intact. There was no transgene expression in nodose ganglion and no change in expression of the acid-sensing ion channel-2 or -3 in nodose ganglion. There was a trend toward decreased expression of transient receptor potential vanilloid-1 receptor mRNA in nodose ganglion, but no difference in the immunochemical staining of transient receptor potential vanilloid-1 receptor in the termination area of the left aortic depressor nerve in S-P467L mice. Although there was no difference in the maximal calcium response to capsaicin in cultured nodose neurons from S-P467L mice, there was decreased desensitization of transient receptor potential vanilloid-1 receptor channels. In conclusion, S-P467L mice exhibit baroreflex dysfunction because of a defect in the afferent limb of the baroreflex arc caused by impaired vascular function, altered vascular structure, or compromised neurovascular coupling. These findings implicate vascular smooth muscle peroxisome proliferator activated receptor-γ as a critical determinant of neurovascular signaling.

Indexed as

AnimalsAutonomic Nervous SystemAutonomic Nervous System DiseasesBaroreflexBlood PressureCalciumCapsaicinCells, CulturedDisease Models, AnimalHeart RateMaleMiceMice, TransgenicMuscle, Smooth, VascularNodose GanglionPPAR gammaCalciumCapsaicinPPAR gammabaroreflexblood pressureheart ratemuscle, smooth, vascularperoxisome proliferator-activated receptorssympathetic nervous system

Identifiers

PMID24914194
PMCPMC4134389
OpenAlexW2105663135

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.